This is the authors' abstract. We don't add key points for this paper.
Compared with wild-type SARS-CoV-2, Omicron S-RBD exhibit higher binding with ACE2 and lower affinity against monoclonal antibodies.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Solanki et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: